Autologous Stem Cell Market Analysis by Source (Bone Marrow, Hematopoietic Stem Cells), by Application (Cancer, Wound Healing, Orthopaedic, Autoimmune Disorders, Cardiovascular, Neurological Disorders), by End User and by Region – Forecast to 2026
- Additional information
- Enquire about
Autologous Stem Cell Market Analysis by Source (Bone Marrow, Hematopoietic Stem Cells), by Application (Cancer, Wound Healing, Orthopaedic, Autoimmune Disorders, Cardiovascular, Neurological Disorders), by End User and by Region - Forecast to 2026
The global autologous stem cell (ASC) market size is expected to witness a CAGR of X.X% during the forecast period. The increasing demand for advanced, effective, and safe transplant therapies is a major factor boosting the market growth. ASC transplantation reduces the risks associated with bio-incompatibility and immunological reactions. Moreover, increasing adoption of ASC in the treatment of skin burns, several cancers, wound healing, cosmetic surgeries, and pressure ulcers is another major driver that propels the growth. However, high cost of the ASC therapies and stringent government regulations are some of the factors hindering the market growth.
Some of the key players in the autologous stem cell market are Novartis AG (Switzerland); Caladrius Biosciences, Inc. (US); BrainStorm Cell Ltd. (US); Cytori Therapeutics Inc. (US); Gilead Sciences Inc. (US); Dendreon Pharmaceuticals LLC (US); Bioheart (U.S.); and Regeneus Ltd (Australia). The leading players operating in the autologous stem cell industry are adopting various strategies including investment in the R&D and new therapy launch to capture a maximum revenue share.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2026. The autologous stem cell market report is categorized into the following segments and subsegments:
Autologous Stem Cell Market, By Source (Revenue, 2017- 2026, USD Billion)
- Hematopoietic Stem Cells
- Bone Marrow
Autologous Stem Cell Market, By Application (Revenue, 2017-2026, USD Billion)
- Wound Healing
- Neurological Disorders
- Cardiovascular Disorders
- Orthopaedic Disorders
- Autoimmune Disorders
Autologous Stem Cell Market, By End-User (Revenue, 2017-2027, USD Billion)
- Ambulatory Surgical Centers
- Research Institutes
Autologous Stem Cell Market, By Region (Revenue, 2017-2026, USD Billion)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Key questions addressed by the research report-
- What are the current market trends (2017 to 2020) and future market forecast from 2021 to 2026 for the market?
- What are the market dynamics and probable opportunities for market players during the forecast period?
- Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
- Which geographies have immense opportunities in different segments and sub-segments of the market?
- What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?